Ref: HHM-3

HybriMax makes use of both DNA amplification and Hybribio ‘ s proprietary “Flow-through Hybridization” Technology (US Patents 5,741,647&6,020, 187) to identify HPV, Thalassemia or STDs subtypes using specific DNA probes with gene-chip technology. A low density macroarray platform provides a rapid, in vitro DNA diagnosis with high sensitivity, specificity and accuracy.